Compare Albertsons Companies Inc (ACI) vs Merck & Co., Inc. (MRK) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Albertsons Companies Inc vs Merck & Co., Inc. — how do they compare? Albertsons Companies Inc trades at $13.98 (market cap $6.93B), while Merck & Co., Inc. trades at $125.9 (market cap $318.26B). The key difference: Merck & Co., Inc. is far larger — about 45.9× Albertsons Companies Inc's market cap, and Albertsons Companies Inc pays the higher dividend (4.81%). Which is the better fit depends on your goals.
| ACI | MRK | |
|---|---|---|
Market Cap | $6.93B | $318.26B |
Sector | Consumer Staples | Health |
52-Week High | $22.33 | $129.52 |
52-Week Low | $13.45 | $77.60 |
Enterprise Value | $22.02B | $361.68B |
Dividend Yield | 4.81% | 2.64% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Merck (MRK) trades at $128.86, up 1.64% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $139.33. The company reported strong recent earnings beats and maintains robust profitability with a 73.91% gross margin. Recent news highlights Merck's strategic acquisition of Terns Pharmaceuticals to bolster its oncology pipeline, reflecting active M&A activity in the pharmaceutical sector.
The outlook is positive given strong fundamentals, strategic acquisitions, and analyst support, but risks include execution of pipeline growth, competitive pressures in oncology, and potential market volatility. The stock's valuation at a P/E of 36.3 appears elevated relative to historical norms, requiring sustained earnings growth to justify current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Albertsons Companies Inc
Albertsons is the second-largest traditional grocer in America, operating 2,276 stores under 24 banners in 34 states (as of the end of fiscal 2021). Around 75% of stores have pharmacies, while nearly 20% also sell fuel. Albertsons has a significant private-label operation, accounting for around 20% of sales (excluding fuel). While its own brand assortment is mainly manufactured by third parties, Albertsons operates 20 food production plants (as of the end of fiscal 2021). Albertsons is a top-two grocer in two thirds of its major markets (as of early 2022, according to company data), and virtually all of its sales come from the United States.
Read more on ACI →About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →
